Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | TNKS | O95271 | 2/20 | 0.40 |
| ▸ | NUDT1 | P36639 | 1/20 | 0.36 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | ACKR3 | P25106 | 1/20 | 0.32 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.31 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.30 |
| ▸ | HTR2C | P28335 | 1/20 | 0.30 |
| ▸ | CCR1 | P32246 | 1/20 | 0.30 |
| ▸ | CCR5 | P51681 | 1/20 | 0.30 |
| ▸ | CCR8 | P51685 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24087286 | 0.80 | L3MBTL1 (0.43) | L3MBTL1TNKSNUDT1HDAC6CYP1A2 | |
| SCHEMBL2260742 | 0.80 | L3MBTL1 (0.67) | L3MBTL1TNKSNUDT1ACKR3HTR2C | |
| SCHEMBL13821670 | 0.78 | L3MBTL1 (0.50) | L3MBTL1TNKSNUDT1ACKR3ADORA2A | |
| SCHEMBL20125026 | 0.78 | L3MBTL1 (0.46) | L3MBTL1TNKSNUDT1ACKR3ADORA2A | |
| SCHEMBL25310988 | 0.77 | NUDT1 (0.45) | L3MBTL1TNKSNUDT1ADORA2AHTR2C | |
| SCHEMBL1348141 | 0.77 | L3MBTL1 (0.62) | L3MBTL1TNKSNUDT1HDAC6HDAC1 | |
| SCHEMBL20125017 | 0.77 | L3MBTL1 (0.41) | L3MBTL1TNKSNUDT1 | |
| SCHEMBL15828611 | 0.77 | TNKS (0.43) | L3MBTL1TNKSNUDT1 | |
| SCHEMBL24857525 | 0.76 | L3MBTL1 (0.47) | L3MBTL1TNKSNUDT1HDAC6CYP3A4 | |
| Hydrochloric Acid SCHEMBL31600948 | 0.76 | NUDT1 (0.44) | L3MBTL1NUDT1ADORA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023091604-A1 | ADENOSINE RECEPTOR ANTAGONISTS | CROSSIGNAL THERAPEUTICS, INC. (US) | 2023-05-25 | — | — | WO | disclosed |
| WO-2023064361-A1 | 7H-PYRROLO[2,3-D]PYRIMIDINES AND PREPARATION AS DYRK1A INHIBITORS | BIOSPLICE THERAPEUTICS, INC. (US) | 2023-04-20 | — | — | WO | disclosed |
| WO-2023034812-A1 | COMPOUNDS AND METHODS FOR MODULATING SPLICING | REMIX THERAPEUTICS INC. (US) | 2023-03-09 | — | — | WO | disclosed |
| EP-3318557-A2 | QUINOLONE COMPOUND | Otsuka Pharmaceutical Co., Ltd. (JP) | 2018-05-09 | — | — | EP | disclosed |